• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RBM15B通过PCNA的m6A修饰促进前列腺癌细胞增殖。

RBM15B Promotes Prostate Cancer Cell Proliferation via PCNA m6A Modification.

作者信息

Cheng Huan, Chen Zeyu, Wang Yong, Ji Chengjian, Wang Junqi, Song Ninghong

机构信息

Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

Department of Urology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221004, China.

出版信息

Cell Biochem Biophys. 2025 Mar;83(1):1237-1248. doi: 10.1007/s12013-024-01558-5. Epub 2024 Oct 3.

DOI:10.1007/s12013-024-01558-5
PMID:39361104
Abstract

Prostate cancer (PC) is the most frequently occurring cancer in men, characterized by the abnormal proliferation of cells within the prostate gland. This study explores the role of RNA binding motif protein 15B (RBM15B) in PC. RBM15B expression levels in PC patients were predicted using the Starbase database. The expression of RBM15B and proliferating cell nuclear antigen (PCNA) expression in PC cells was detected. Following RBM15B knockdown, cell proliferation assays were conducted. N6-methyladenosine (m6A) levels in PC cells were quantified, and RNA immunoprecipitation was performed to analyze the binding of m6A and YTH N-methyladenosine RNA binding protein 1 (YTHDF1) on PCNA mRNA. The stability of PCNA mRNA was assessed after treatment with actinomycin D. An in vivo nude mouse xenograft model was created to validate the role of RBM15B. The findings revealed the upregulation of RBM15B in PC. RBM15B knockdown resulted in decreased proliferation, colony formation, and EdU-positive cells. Mechanical analysis showed that RBM15B facilitated m6A modification of PCNA mRNA, leading to increasing m6A methylation. YTHDF1 bound to these m6A sites on PCNA mRNA, thus stabilizing it. Furthermore, PCNA overexpression mitigated the effects of RBM15B knockdown on PC cell proliferation. In conclusion, RBM15B promotes PC cell proliferation by enhancing the stability of PCNA mRNA through YTHDF1-mediated m6A modification.

摘要

前列腺癌(PC)是男性中最常见的癌症,其特征是前列腺腺体内细胞异常增殖。本研究探讨了RNA结合基序蛋白15B(RBM15B)在前列腺癌中的作用。使用Starbase数据库预测前列腺癌患者中RBM15B的表达水平。检测前列腺癌细胞中RBM15B的表达和增殖细胞核抗原(PCNA)的表达。在敲低RBM15B后,进行细胞增殖试验。对前列腺癌细胞中的N6-甲基腺苷(m6A)水平进行定量,并进行RNA免疫沉淀以分析m6A和YTH N-甲基腺苷RNA结合蛋白1(YTHDF1)在PCNA mRNA上的结合。在用放线菌素D处理后评估PCNA mRNA的稳定性。建立体内裸鼠异种移植模型以验证RBM15B的作用。研究结果显示前列腺癌中RBM15B上调。敲低RBM15B导致增殖、集落形成和EdU阳性细胞减少。机制分析表明,RBM15B促进PCNA mRNA的m6A修饰,导致m6A甲基化增加。YTHDF1与PCNA mRNA上的这些m6A位点结合,从而使其稳定。此外,PCNA过表达减轻了RBM15B敲低对前列腺癌细胞增殖的影响。总之,RBM15B通过YTHDF1介导的m6A修饰增强PCNA mRNA的稳定性,从而促进前列腺癌细胞增殖。

相似文献

1
RBM15B Promotes Prostate Cancer Cell Proliferation via PCNA m6A Modification.RBM15B通过PCNA的m6A修饰促进前列腺癌细胞增殖。
Cell Biochem Biophys. 2025 Mar;83(1):1237-1248. doi: 10.1007/s12013-024-01558-5. Epub 2024 Oct 3.
2
RNA N6-methyladenosine-modified-binding protein YTHDF1 promotes prostate cancer progression by regulating androgen function-related gene TRIM68.RNA N6-甲基腺苷修饰结合蛋白 YTHDF1 通过调节雄激素功能相关基因 TRIM68 促进前列腺癌的进展。
Eur J Med Res. 2023 Dec 2;28(1):552. doi: 10.1186/s40001-023-01533-5.
3
YTHDF1 promotes gallbladder cancer progression via post-transcriptional regulation of the m6A/UHRF1 axis.YTHDF1 通过转录后调控 m6A/UHRF1 轴促进胆囊癌进展。
J Cell Mol Med. 2024 May;28(9):e18328. doi: 10.1111/jcmm.18328.
4
Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).甲基化识别蛋白 YTH N6-甲基腺苷 RNA 结合蛋白 1(YTHDF1)通过调节 CCR4-NOT 转录复合物亚基 7(CNOT7)的 m6A 水平调节骨肉瘤的增殖、迁移和侵袭。
Bioengineered. 2022 Mar;13(3):5236-5250. doi: 10.1080/21655979.2022.2037381.
5
METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.METTL3 通过诱导 HOXC6 m6A 修饰并通过 IGF2BP2 依赖性机制稳定其表达促进前列腺癌进展。
Mol Cell Biochem. 2024 Jul;479(7):1707-1720. doi: 10.1007/s11010-024-05023-y. Epub 2024 May 31.
6
Propofol attenuates prostate cancer progression by upregulating TRHDE-AS1 expression, and METTL14 could mediate its m6A modification.异丙酚通过上调 TRHDE-AS1 的表达来抑制前列腺癌的进展,而 METTL14 可以介导其 m6A 修饰。
Clin Exp Pharmacol Physiol. 2024 Nov;51(11):e13924. doi: 10.1111/1440-1681.13924.
7
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.YTHDF2 通过 N6-甲基腺苷依赖性方式介导肿瘤抑制因子的 mRNA 降解,从而诱导前列腺癌中 AKT 的磷酸化。
Mol Cancer. 2020 Oct 29;19(1):152. doi: 10.1186/s12943-020-01267-6.
8
N6-methyladenosine-modified circRPS6KC1 regulated cellular senescence in prostate cancer via FOXM1/PCNA axis.N6-甲基腺苷修饰的circRPS6KC1通过FOXM1/PCNA轴调节前列腺癌中的细胞衰老。
Cell Signal. 2025 Jan;125:111510. doi: 10.1016/j.cellsig.2024.111510. Epub 2024 Nov 15.
9
N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination.N6-甲基腺苷通过抑制 PCNA 泛素化增强 ENO1 的翻译,促进膀胱癌的进展。
Cancer Lett. 2024 Jul 28;595:217002. doi: 10.1016/j.canlet.2024.217002. Epub 2024 May 30.
10
RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.RNA 去甲基酶 ALKBH5 通过 m6A-YTHDF2 依赖的方式在后转录水平激活 PER1 来阻止胰腺癌细胞的进展。
Mol Cancer. 2020 May 19;19(1):91. doi: 10.1186/s12943-020-01158-w.

本文引用的文献

1
N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination.N6-甲基腺苷通过抑制 PCNA 泛素化增强 ENO1 的翻译,促进膀胱癌的进展。
Cancer Lett. 2024 Jul 28;595:217002. doi: 10.1016/j.canlet.2024.217002. Epub 2024 May 30.
2
RNA m6a Methylation Regulator Expression in Castration-Resistant Prostate Cancer Progression and Its Genetic Associations.RNA m6A甲基化调节因子在去势抵抗性前列腺癌进展中的表达及其遗传关联
Cancers (Basel). 2024 Mar 27;16(7):1303. doi: 10.3390/cancers16071303.
3
Resistomycin Suppresses Prostate Cancer Cell Growth by Instigating Oxidative Stress, Mitochondrial Apoptosis, and Cell Cycle Arrest.
利福平霉素通过引发氧化应激、线粒体凋亡和细胞周期停滞来抑制前列腺癌细胞生长。
Molecules. 2023 Nov 30;28(23):7871. doi: 10.3390/molecules28237871.
4
N-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via mA/PD-L1 manner.N6-甲基腺苷调控因子 YTHDF1 通过 mA/PD-L1 途径抑制前列腺癌中 CD8+T 细胞介导的抗肿瘤免疫和铁死亡。
Apoptosis. 2024 Feb;29(1-2):142-153. doi: 10.1007/s10495-023-01885-7. Epub 2023 Sep 12.
5
ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.ELK1 介导的 YTHDF1 通过促进 Polo-like kinase 1 的翻译以依赖 m6A 的方式促进前列腺癌的进展。
Int J Biol Sci. 2022 Oct 18;18(16):6145-6162. doi: 10.7150/ijbs.75063. eCollection 2022.
6
Complexities of Prostate Cancer.前列腺癌的复杂性。
Int J Mol Sci. 2022 Nov 17;23(22):14257. doi: 10.3390/ijms232214257.
7
Unveiling the m6A Methylation Regulator Links between Prostate Cancer and Periodontitis by Transcriptomic Analysis.通过转录组分析揭示前列腺癌和牙周炎之间的 m6A 甲基化调节剂关联。
Dis Markers. 2022 Sep 12;2022:4030046. doi: 10.1155/2022/4030046. eCollection 2022.
8
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches.前列腺癌综述:遗传学、诊断、治疗选择和替代方法。
Molecules. 2022 Sep 5;27(17):5730. doi: 10.3390/molecules27175730.
9
α-Terthienyl induces prostate cancer cell death through inhibiting androgen receptor expression.α-噻吩并[3,2-b]噻吩诱导前列腺癌细胞死亡通过抑制雄激素受体表达。
Biomed Pharmacother. 2022 Aug;152:113266. doi: 10.1016/j.biopha.2022.113266. Epub 2022 Jun 9.
10
YY1-Targeted RBM15B Promotes Hepatocellular Carcinoma Cell Proliferation and Sorafenib Resistance by Promoting TRAM2 Expression in an m6A-Dependent Manner.以YY1为靶点的RBM15B通过以m6A依赖的方式促进TRAM2表达来促进肝癌细胞增殖和索拉非尼耐药。
Front Oncol. 2022 Apr 14;12:873020. doi: 10.3389/fonc.2022.873020. eCollection 2022.